Concepedia

E Ber

EB

10

Publications

931

Citations

10

H-Index

1974

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Leibniz Institute for Neurobiology

E Ber is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

MedicineBiochemistryPharmacologyImmunologyMolecular PharmacologyBiosynthesisCell BiologyDrug DiscoveryGene ExpressionPharmacotherapy

Publications per year

1974–2005

10

Publications

10

Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets

F.D. Tattersall, Wayne Rycroft, B. Francis et al. · Neuropharmacology · 1996 · 211 citations

Signal Transduction, Signaling Pathway, Medicine +6

Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.

Margaret A. Cascieri, E Ber, Tung M. Fong et al. · Molecular Pharmacology · 1992 · 136 citations

The novel NK1 receptor antagonist MK–0869 (L–754,030) and its water soluble phosphoryl prodrug, L–758,298, inhibit acute and delayed cisplatin-induced emesis in ferrets

F.D. Tattersall, Wayne Rycroft, M. Cumberbatch et al. · Neuropharmacology · 2000 · 136 citations

Molecular Pharmacology, Signaling Pathway, Cisplatin-induced Emesis +7

Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom.

Gary G. Chicchi, Guillermo Giménez‐Gallego, E Ber et al. · Journal of Biological Chemistry · 1988 · 127 citations · Full text

Toxinology, Potent Inhibitor, Apamin Binding +16

Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.

Margaret A. Cascieri, R R Huang, Tung M. Fong et al. · Molecular Pharmacology · 1992 · 121 citations

Rows per page

1–5 of 10